Atropine Sulfate 0.01% Eye Drops

DRUG3 trials

Sponsors

Medical Center - University Of Freiburg, Pharma Stulln GmbH, Sultan Qaboos University

Conditions

Myopia progression in childrenMyopia, ProgressiveProgressive myopia

Early Phase 1

Atropine 0.01% Eye Drops in Myopia Study

Sultan Qaboos UniversityMyopia, Progressive

Start: 2018-12-20End: 2022-01-01Target: 150Updated: 2020-08-06

Phase 2

A randomized, double-blind, placebo-controlled dose-finding study of 0.05%, 0.025%, 0.01% and 0.005% atropine eye drops to inhibit myopia progression in children in a European population

CompletedCTIS2024-516758-23-00

Pharma Stulln GmbHMyopia progression in children

Start: 2022-09-19End: 2025-04-15Target: 135Updated: 2024-12-09

Phase 3

Low-dose AtropIne for Myopia control in children

Active, not recruitingCTIS2024-513091-17-00

Medical Center - University Of FreiburgProgressive myopia

Start: 2021-09-29Target: 300Updated: 2024-10-24